Logo image of 6MK.DE

MERCK & CO. INC. (6MK.DE) Stock Price, Quote, News and Overview

FRA:6MK - Deutsche Boerse Ag - US58933Y1055 - Common Stock - Currency: EUR

68.8  -0.4 (-0.58%)

6MK.DE Quote, Performance and Key Statistics

MERCK & CO. INC.

FRA:6MK (5/21/2025, 7:00:00 PM)

68.8

-0.4 (-0.58%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High125.6
52 Week Low65.5
Market Cap173.13B
Shares2.52B
Float2.51B
Yearly Dividend2.77
Dividend Yield4.33%
PE10
Fwd PE7.9
Earnings (Next)07-29 2025-07-29/bmo
IPO01-01 1941-01-01


6MK.DE short term performance overview.The bars show the price performance of 6MK.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

6MK.DE long term performance overview.The bars show the price performance of 6MK.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of 6MK.DE is 68.8 EUR. In the past month the price increased by 0.58%. In the past year, price decreased by -42.67%.

MERCK & CO. INC. / 6MK Daily stock chart

6MK.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 52.17 600.93B
1LLY.MI ELI LILLY & CO 52.12 600.36B
ZEG.DE ASTRAZENECA PLC 19.1 386.77B
1JNJ.MI JOHNSON & JOHNSON 15.22 325.25B
JNJ.DE JOHNSON & JOHNSON 15.15 323.62B
NOV.DE NOVO NORDISK A/S-B 19.46 266.03B
RHO.DE ROCHE HOLDING AG-BR 14.93 242.78B
1SAN.MI SANOFI 13.96 230.07B
SNW.DE SANOFI 13.91 229.11B
SAN.PA SANOFI 13.88 228.67B
NOT.DE NOVARTIS AG-REG 13.69 197.94B
1MRKX.MI MERCK & CO. INC. 9.9 171.37B

About 6MK.DE

Company Profile

6MK logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY US

Employees: 74000

6MK Company Website

6MK Investor Relations

Phone: 19087404000

MERCK & CO. INC. / 6MK.DE FAQ

What is the stock price of MERCK & CO. INC. today?

The current stock price of 6MK.DE is 68.8 EUR. The price decreased by -0.58% in the last trading session.


What is the ticker symbol for MERCK & CO. INC. stock?

The exchange symbol of MERCK & CO. INC. is 6MK and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is 6MK.DE stock listed?

6MK.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for MERCK & CO. INC. stock?

32 analysts have analysed 6MK.DE and the average price target is 94.66 EUR. This implies a price increase of 37.58% is expected in the next year compared to the current price of 68.8. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (6MK.DE) has a market capitalization of 173.13B EUR. This makes 6MK.DE a Large Cap stock.


How many employees does MERCK & CO. INC. have?

MERCK & CO. INC. (6MK.DE) currently has 74000 employees.


What are the support and resistance levels for MERCK & CO. INC. (6MK.DE) stock?

MERCK & CO. INC. (6MK.DE) has a support level at 68.6 and a resistance level at 69.83. Check the full technical report for a detailed analysis of 6MK.DE support and resistance levels.


Is MERCK & CO. INC. (6MK.DE) expected to grow?

The Revenue of MERCK & CO. INC. (6MK.DE) is expected to grow by 1.68% in the next year. Check the estimates tab for more information on the 6MK.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MERCK & CO. INC. (6MK.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MERCK & CO. INC. (6MK.DE) stock pay dividends?

MERCK & CO. INC. (6MK.DE) has a dividend yield of 4.33%. The yearly dividend amount is currently 2.77. Check the full fundamental report for a detailed analysis of 6MK.DE dividend history, reliability and sustainability.


When does MERCK & CO. INC. (6MK.DE) report earnings?

MERCK & CO. INC. (6MK.DE) will report earnings on 2025-07-29, before the market open.


What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (6MK.DE)?

The PE ratio for MERCK & CO. INC. (6MK.DE) is 10. This is based on the reported non-GAAP earnings per share of 6.88 and the current share price of 68.8 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 6MK.DE.


6MK.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 6MK.DE. When comparing the yearly performance of all stocks, 6MK.DE is a bad performer in the overall market: 94.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

6MK.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to 6MK.DE. 6MK.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

6MK.DE Financial Highlights

Over the last trailing twelve months 6MK.DE reported a non-GAAP Earnings per Share(EPS) of 6.88. The EPS increased by 258.99% compared to the year before.


Industry RankSector Rank
PM (TTM) 27.27%
ROA 15.14%
ROE 36.07%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%7.25%
Sales Q2Q%-1.56%
EPS 1Y (TTM)258.99%
Revenue 1Y (TTM)4.1%

6MK.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 78% to 6MK.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 17.73% and a revenue growth 1.68% for 6MK.DE


Ownership
Inst Owners79.95%
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
Analysts
Analysts77.5
Price Target94.66 (37.59%)
EPS Next Y17.73%
Revenue Next Year1.68%